DCM
IRWD icon

Dupont Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Dupont Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,629
Closed -$222K – 1354
2020
Q3 		$222K Sell
24,629
-20,951
-46% -$208K ﹤0.01% 1086
2020
Q2 		$470K Sell
45,580
-24,994
-35% -$256K 0.01% 810
2020
Q1 		$712K Hold
70,574
– – 0.02% 552
2019
Q4 		$939K Buy
+70,574
New +$778K 0.02% 594

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dupont Capital Management's IRWD Position: Q4 2020 in Review

Dupont Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2020, closing a stake of 24,629 shares — an estimated $222K sold.

Dupont Capital Management first reported a position in IRWD in Q4 2019 and held it in 4 quarters. The position peaked at $939K in Q4 2019. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

  • Dupont Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Dupont Capital Management sold 24,629 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $222K.
  • Dupont Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Dupont Capital Management's Ironwood Pharmaceuticals position peaked at $939K in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.